Oncogenic IRFs Provide a Survival Advantage for Epstein-Barr Virus- or Human T-Cell Leukemia Virus Type 1-Transformed Cells through Induction of BIC Expression

TLR4 Ligands Induce IFN-  Production by Mouse Conventional Dendritic Cells and Human Monocytes after IFN-  Priming

(2014) C. Richez et al.   JOURNAL OF IMMUNOLOGY

MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia

(2011) K. Vargova et al.   BLOOD

Upregulation of MiR-155 in Nasopharyngeal Carcinoma is Partly Driven by LMP1 and LMP2A and Downregulates a Negative Prognostic Marker JMJD1A

(2011) Zi-Ming Du et al.   PLoS One

Regulation of immunity and oncogenesis by the IRF transcription factor family

(2010) David Savitsky et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Identification of MyD88 as a novel target of miR-155, involved in negative regulation ofHelicobacter pylori-induced inflammation

(2010) Bin Tang et al.   FEBS LETTERS

MicroRNA-155Regulates Cell Survival, Growth, and Chemosensitivity by TargetingFOXO3ain Breast Cancer

(2010) William Kong et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

microRNA profiling in Epstein–Barr virus-associated B-cell lymphoma

(2010) Jochen Imig et al.   NUCLEIC ACIDS RESEARCH

Targeting of SMAD5 links microRNA-155 to the TGF-  pathway and lymphomagenesis

(2010) D. Rai et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

miR-21as a key regulator of oncogenic processes

(2009) S. Duygu Selcuklu et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

miR-155 gene: A typical multifunctional microRNA

(2009) Isabella Faraoni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia

(2009) Y. Yamanaka et al.   BLOOD

MicroRNA Control in the Immune System: Basic Principles

(2009) Changchun Xiao et al.   CELL

Structural insights into interferon regulatory factor activation

(2009) Weijun Chen et al.   CELLULAR SIGNALLING

IRF4: Immunity. Malignancy! Therapy?

(2009) A. L. Shaffer et al.   CLINICAL CANCER RESEARCH

Onco-miR-155 targets SHIP1 to promote TNFα-dependent growth of B cell lymphomas

(2009) Irene M. Pedersen et al.   EMBO Molecular Medicine

Foxp3-Dependent MicroRNA155 Confers Competitive Fitness to Regulatory T Cells by Targeting SOCS1 Protein

(2009) Li-Fan Lu et al.   IMMUNITY

miR-155: On the Crosstalk Between Inflammation and Cancer

(2009) Esmerina Tili et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Human T Cell Lymphotropic Virus 1 Manipulates Interferon Regulatory Signals by Controlling the TAK1-IRF3 and IRF4 Pathways

(2009) Shunsuke Suzuki et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Interferon Regulatory Factors in Hematopoietic Cell Differentiation and Immune Regulation

(2009) Angela Battistini   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

Functional Analysis of a Dominant Negative Mutation of Interferon Regulatory Factor 5

(2009) Long Yang et al.   PLoS One

Inositol phosphatase SHIP1 is a primary target of miR-155

(2009) R. M. O'Connell et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The IRF Family Transcription Factors in Immunity and Oncogenesis

(2008) Tomohiko Tamura et al.   Annual Review of Immunology

Interferon regulatory factor family of transcription factors and regulation of oncogenesis

(2008) Akinori Takaoka et al.   CANCER SCIENCE

MicroRNAs in normal and malignant hematopoiesis

(2008) Ramiro Garzon et al.   CURRENT OPINION IN HEMATOLOGY

MicroRNAs in the immune response

(2008) Irene Pedersen et al.   CYTOKINE

Interferon Regulatory Factor 4 Is Involved in Epstein-Barr Virus-Mediated Transformation of Human B Lymphocytes

(2008) D. Xu et al.   JOURNAL OF VIROLOGY

Epstein-Barr Virus-Induced miR-155 Attenuates NF- B Signaling and Stabilizes Latent Virus Persistence

(2008) F. Lu et al.   JOURNAL OF VIROLOGY

A Functional MicroRNA-155 Ortholog Encoded by the Oncogenic Marek's Disease Virus

(2008) Y. Zhao et al.   JOURNAL OF VIROLOGY

MicroRNA-155 Is an Epstein-Barr Virus-Induced Gene That Modulates Epstein-Barr Virus-Regulated Gene Expression Pathways

(2008) Q. Yin et al.   JOURNAL OF VIROLOGY

TRAF6 and the Three C-Terminal Lysine Sites on IRF7 Are Required for Its Ubiquitination-Mediated Activation by the Tumor Necrosis Factor Receptor Family Member Latent Membrane Protein 1

(2008) S. Ning et al.   MOLECULAR AND CELLULAR BIOLOGY

IRF4 addiction in multiple myeloma

(2008) Arthur L. Shaffer et al.   NATURE

Cellular versus viral microRNAs in host-virus interaction

(2008) Z. Ghosh et al.   NUCLEIC ACIDS RESEARCH

Epstein–Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway

(2008) Graziana Gatto et al.   NUCLEIC ACIDS RESEARCH

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3

(2008) Y.-J. Song et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epstein–Barr virus growth/latency III program alters cellular microRNA expression

(2008) Jennifer E. Cameron et al.   VIROLOGY